Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness

导出原文传递

翻译打印收藏纠错

作者： Grandits, Alexander Michael ^[1] ; Chi Huu Nguyen ^[2] ; Schlerka, Angela ^[3] ; Hackl, Hubert ^[4] ; Sill, Heinz ^[5] ; Etzler, Julia ; Heyes, Elizabeth ; Stoiber, Dagmar ; Grebien, Florian ; Heller, Gerwin ; Wieser, Rotraud

作者单位： Univ Vet Med, Inst Med Biochem, Vienna, Austria ^[1] Med Univ Innsbruck, Bioctr, Inst Bioinformat, Innsbruck, Austria ^[2] Med Univ Vienna, Dept Med 1, Div Oncol, Vienna, Austria ^[3] Med Univ Graz, Div Hematol, Graz, Austria ^[4] Karl Landsteiner Univ Hlth Sci, Dept Pharmacol Physiol & Microbiol, Div Pharmacol, Krems, Austria ^[5]

发布时间 2021-12-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Leukemia

2021年35卷10期

2827-2839页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness

Leukemia

相似文献

Leukemia

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness

Leukemia

相似文献

Leukemia

相关期刊

检索历史清除